GENECOPOEIA, INC.

Genecoepoeia, Inc. specializes in molecular biology research and development services, with a focus on cloning, plasmid vector construction, and genetic reagent production for biomedical applications. Their technical expertise centers on gene synthesis, recombinant DNA technology, and the preparation of high-purity expression-ready constructs, including shuttle clones without stop codons for functional protein studies. They deliver custom biotechnological reagents tailored to translational research needs, supporting target validation, functional genomics, and assay development. Their precision in plasmid design and purification distinguishes them in niche markets requiring high-fidelity genetic tools for immunology and signaling pathway research. The company maintains consistent engagement with the Department of Health and Human Services, providing molecular biology reagents and genetic constructs that support public health research initiatives, particularly in immunogenetics and gene expression analysis. They also serve the Department of Veterans Affairs with specialized biological samples, such as human serum, indicating involvement in clinical biomarker studies and translational immunology programs. Their relationship with these agencies reflects a pattern of supporting investigator-driven research through precise, scalable biological tooling. Genecoepoeia’s primary focus lies in NAICS 541714, which encompasses non-nanobiotechnology research in biotechnology, particularly gene cloning and recombinant protein systems. Their secondary work in NAICS 541690 demonstrates capacity to deliver technical consulting around biological sample procurement and experimental design. This positions them as a specialized supplier within the academic and federal research ecosystem, serving as a critical enabler for labs requiring off-the-shelf genetic tools rather than broad-spectrum contract research. Based in Rockville, Maryland, Genecoepoeia, Inc. operates as a small business with no federal certifications on record. Their geographic proximity to federal research hubs enhances accessibility for time-sensitive biological deliveries and collaborative projects within the National Institutes of Health corridor.